Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)
ClinicalTrials.gov study NCT01854658. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00744978. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
ClinicalTrials.gov study NCT01312961. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata
ClinicalTrials.gov study NCT04556734. IPD Sharing: YES. Countries: 2. Publications: 2.
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
ClinicalTrials.gov study NCT03721172. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
ClinicalTrials.gov study NCT01512849. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
ClinicalTrials.gov study NCT02322775. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
ClinicalTrials.gov study NCT02479412. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03482011. IPD Sharing: YES. Countries: 9. Publications: 1.
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03524092. IPD Sharing: YES. Countries: 34. Publications: 10.
A Registry of Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02786186. IPD Sharing: UNDECIDED. Countries: 8. Publications: 2.
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04800315. IPD Sharing: YES. Countries: 6. Publications: 1.
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
ClinicalTrials.gov study NCT02058368. IPD Sharing: YES. Countries: 4. Publications: 1.
To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT03656042. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01899729. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
ClinicalTrials.gov study NCT03052751. IPD Sharing: Not stated. Countries: 7. Publications: 4.
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00663052. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00678210. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT01453569. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
ClinicalTrials.gov study NCT05369403. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.